U.S. Renal Care

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
	R1 Therapeutics	$78.0M R1 Therapeutics Series A	Abingworth, F-Prime Capital, Andrew Sinclair, Chong Xu, DaVita Venture Group, Chong Xu	Ben Auspitz, SymBiosis

Total Raised

N/A

Valuation

N/A

Key people at U.S. Renal Care.

Andy Mitzen

Key people at U.S. Renal Care.